Real-life long-term omalizumab therapy in children with severe allergic asthma. [electronic resource]
Producer: 20160603Description: 856-9 p. digitalISSN:- 1399-3003
- Adolescent
- Anti-Asthmatic Agents -- adverse effects
- Antibodies, Monoclonal, Humanized -- adverse effects
- Asthma -- drug therapy
- Child
- Cohort Studies
- Dose-Response Relationship, Drug
- Drug Administration Schedule
- Female
- Follow-Up Studies
- Humans
- Injections, Subcutaneous
- Long-Term Care
- Male
- Omalizumab -- therapeutic use
- Recurrence
- Retrospective Studies
- Severity of Illness Index
- Treatment Outcome
No physical items for this record
Publication Type: Letter; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.